Shuchen Hu

422 total citations · 1 hit paper
14 papers, 243 citations indexed

About

Shuchen Hu is a scholar working on Economics and Econometrics, Finance and Epidemiology. According to data from OpenAlex, Shuchen Hu has authored 14 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Economics and Econometrics, 3 papers in Finance and 3 papers in Epidemiology. Recurrent topics in Shuchen Hu's work include Pharmaceutical Economics and Policy (5 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Healthcare Systems and Reforms (3 papers). Shuchen Hu is often cited by papers focused on Pharmaceutical Economics and Policy (5 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Healthcare Systems and Reforms (3 papers). Shuchen Hu collaborates with scholars based in China, United Kingdom and Pakistan. Shuchen Hu's co-authors include Caijun Yang, Zaheer‐Ud‐Din Babar, Khezar Hayat, Amna Saeed, Ali Hassan Gillani, Sumaira Omer, Sundus Shukar, Yu Fang, Yu Fang and Caijun Yang and has published in prestigious journals such as PLoS ONE, Journal of Alloys and Compounds and Journal of the European Ceramic Society.

In The Last Decade

Shuchen Hu

14 papers receiving 229 citations

Hit Papers

Drug Shortage: Causes, Impact, and Mitigation Strategies 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Drug Shortage: Causes, Impact, and Mitigation Strategies
    2021 161 citations Sundus Shukar, Khezar Hayat et al. Frontiers in Pharmacology profile →

Peers

Shuchen Hu
Caijun Yang China
Sundus Shukar China
Sumaira Omer China
Tomasz Bochenek Poland
Hussain Abdulrahman Al‐Omar Saudi Arabia
Cynthia Reilly United States
Claudia Habl Austria
Kim Pauwels Belgium
Luwen Shi China
Nenad Miljković Italy
Caijun Yang China
Shuchen Hu
Citations per year, relative to Shuchen Hu Shuchen Hu (= 1×) peers Caijun Yang

Countries citing papers authored by Shuchen Hu

Since Specialization
Citations

This map shows the geographic impact of Shuchen Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuchen Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuchen Hu more than expected).

Fields of papers citing papers by Shuchen Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuchen Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuchen Hu. The network helps show where Shuchen Hu may publish in the future.

Co-authorship network of co-authors of Shuchen Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuchen Hu. A scholar is included among the top collaborators of Shuchen Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuchen Hu. Shuchen Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hu, Shuchen, et al.. (2024). Changes in insulin utilization in China from 2020 to 2022. Diabetes Obesity and Metabolism. 26(12). 5681–5689. 1 indexed citations
2.
Xu, Sen, et al.. (2024). Time trends and regional variation in utilization of antidiabetic medicines in China, 2015–2022. Diabetes Obesity and Metabolism. 26(7). 2752–2760. 4 indexed citations
3.
Wang, Jiahui, Xu Guo, Shuchen Hu, et al.. (2024). Enhanced ionic conductivity in Na3Zr2Si2PO12 solid electrolyte via glass addition with low sintering temperature. Journal of the European Ceramic Society. 45(5). 117125–117125. 4 indexed citations
4.
Wang, Jiahui, Xu Guo, Shuchen Hu, et al.. (2024). Enhanced ionic conductivity in Na3Zr2Si2PO12 NASICON-type solid electrolytes by adding Mg2+-ions. Journal of Alloys and Compounds. 988. 174327–174327. 12 indexed citations
5.
Cheng, Xiang, Sha Li, Jinwei Zhang, et al.. (2023). Evaluation of the effect of managing oxycodone/acetaminophen as a psychotropic medicine: An interrupted time-series study. Frontiers in Pharmacology. 14. 1079972–1079972. 1 indexed citations
6.
Hu, Shuchen, Jinwei Zhang, Jianwei Li, et al.. (2023). The impact of drug shortages on drug prices: evidence from China. Frontiers in Public Health. 11. 1185356–1185356. 4 indexed citations
7.
Hu, Shuchen, et al.. (2022). Procurement of medicines to treat cancer, 2015–2020, China. Bulletin of the World Health Organization. 100(12). 758–768. 3 indexed citations
8.
Cheng, Xiang, et al.. (2021). Clinical Consumption of Compound Opioid Analgesics in China: A Retrospective Analysis of National Data 2015–2018. Biological and Pharmaceutical Bulletin. 44(9). 1316–1322. 1 indexed citations
9.
10.
Shukar, Sundus, Khezar Hayat, Amna Saeed, et al.. (2021). Drug Shortage: Causes, Impact, and Mitigation Strategies. Frontiers in Pharmacology. 12. 161 indexed citations breakdown →
11.
12.
Yang, Caijun, Shuchen Hu, Dan Ye, et al.. (2020). Evaluating Price and Availability of Essential Medicines in China: A Mixed Cross-Sectional and Longitudinal Study. Frontiers in Pharmacology. 11. 602421–602421. 12 indexed citations
13.
14.
Hu, Shuchen, Chen Chen, Fei Xue, et al.. (2019). The Effects of a New Public Medicine Procurement Policy on Medicine Price in Shaanxi Province, Western China: An Interrupted Time Series Analysis. Frontiers in Pharmacology. 10. 950–950. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caijun Yang Breakdown of academic impact, for papers by Sundus Shukar Breakdown of academic impact, for papers by Sumaira Omer Breakdown of academic impact, for papers by Tomasz Bochenek Breakdown of academic impact, for papers by Hussain Abdulrahman Al‐Omar Breakdown of academic impact, for papers by Cynthia Reilly Breakdown of academic impact, for papers by Claudia Habl Breakdown of academic impact, for papers by Kim Pauwels Breakdown of academic impact, for papers by Luwen Shi Breakdown of academic impact, for papers by Nenad Miljković
Rankless by CCL
2026